We are actively expanding our range of in-vitro diagnostic kits beyond oncology, focusing on essential parameters in infectious disease, metabolic disorders, and general health screening. This includes rapid and laboratory-based tests for liver and kidney function, cardiovascular markers, infectious diseases like vector borne (e.g., malaria, dengue, typhoid), blood borne, viral, and hormonal assays. Also a series of rapid diagnostic kits aimed at empowering both healthcare professionals and individuals to monitor key health indicators in a fast and convenient manner. These lateral flow and reagent-strip based kits cover parameters such as blood glucose, hemoglobin, cholesterol, ketones, and urine markers. Designed for point-of-care use, these kits are suitable for clinics, home care, and health camps. The goal is to enhance early detection of metabolic and nutritional conditions such as diabetes, anemia, and renal imbalance.
Our IVD development is backed by internal research and validation protocols, conducted in our dedicated laboratory within a cleanroom-controlled environment.
The objective is to offer clinically relevant, cost-effective solutions that improve diagnostic efficiency in primary and secondary healthcare settings. All kits are being designed to integrate with existing equipment used in Indian diagnostic labs and are being evaluated for ease of use, shelf-life stability, and reproducibility. APPIDI Healthcare is committed to supporting preventive healthcare and early diagnosis through scalable and high-quality diagnostic tools, bridging the gap between advanced diagnostic science and accessible public health.